Vaccines for Older Adults: Current Practices and Future Opportunities. Группа авторов

      References

1Ciabattini A, Nardini C, Santoro F, Garagnani P, Franceschi C, Medaglini D: Vaccination in the elderly: the challenge of immune changes with aging. Semin Immunol 2018;40:83–94.

2Wong GCL, Narang V, Lu Y, Camous X, Nyunt MSZ, Carre C, Tan C, Xian CH, Chong J, Chua M, How W, Mok E, Tambyah P, Poidinger M, Abel B, Burdin N, Quemeneur L, Bosco N, Ng TP, Larbi A: Hallmarks of improved immunological responses in the vaccination of more physically active elderly females. Exerc Immunol Rev 2019;25:20–33.

3Weinberger B: Adjuvant strategies to improve vaccination of the elderly population. Curr Opin Pharmacol 2018;41:34–41.

4Del Giudice G, Goronzy JJ, Grubeck-Loebenstein B, Lambert PH, Mrkvan T, Stoddard JJ, Doherty TM: Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging. NPJ Aging Mech Dis 2017;4:1.

5Pera A, Campos C, López N, Hassouneh F, Alonso C, Tarazona R, Solana R: Immunosenescence: implications for response to infection and vaccination in older people. Maturitas 2015;82:50–55.

6Camous X, Visan L, Ying CTT, Abel B, Nyunt MSZ, Narang V, Poidinger M, Carre C, Sesay S, Bosco N, Burdin N, Tambyah PA, Pin NT, Larbi A: Healthy elderly Singaporeans show no age-related humoral hyporesponsiveness nor diminished plasmablast generation in response to influenza vaccine. Immun Ageing 2018;15:28.

7Narang V, Lu Y, Tan C, Camous XFN, Nyunt SZ, Carre C, Mok EWH, Wong G, Maurer-Stroh S, Abel B, Burdin N, Poidinger M, Tambyah PA, Bosco N, Visan L, Ng TP, Larbi A: Influenza vaccine-induced antibody responses are not impaired by frailty in the community-dwelling elderly with natural influenza exposure. Front Immunol 2018;9:2465.

      8Schwarz TF, Volpe S, Catteau G, Chlibek R, David MP, Richardus JH, Lal H, Oostvogels L, Pauksens K, Ravault S, Rombo L, Sonder G, Smetana J, Heineman T, Bastidas A: Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults. Hum Vaccin Immunother 2018;14:1370–1377.

9Weinberger B: Vaccines for the elderly: current use and future challenges. Immun Ageing 2018;15:3.

10Furman D, Davis MM: New approaches to understanding the immune response to vaccination and infection. Vaccine 2015;33:5271–5281.

11Poland GA, Ovsyannikova IG, Kennedy RB: Personalized vaccinology: a review. Vaccine 2018;36:5350–5357.

12Kared H, Martelli S, Tan SW, Simoni Y, Chong ML, Yap SH, Newell EW, Pender SLF, Kamarulzaman A, Rajasu­riar R, Larbi A: Adaptive NKG2C+CD57+ natural killer cell and Tim-3 expression during viral infections. Front Immunol 2018;9:686.

13Iwasaki A, Medzhitov R: Regulation of adaptive immunity by the innate immune system. Science 2010;327:291–295.

14Palgen JL, Tchitchek N, Huot N, Elhmouzi-Younes J, Lefebvre C, Rosenbaum P, Dereuddre-Bosquet N, Martinon F, Hocini H, Cosma A, Müller-Trutwin M, Lévy Y, Le Grand R, Beignon AS: NK cell immune responses differ after prime and boost vaccination. J Leukoc Biol 2019;105:1055–1073.

15Nikzad R, Angelo LS, Aviles-Padilla K, Le DT, Singh VK, Bimler L, Vukmanovic-Stejic M, Vendrame E, Ranganath T, Simpson L, Haigwood NL, Blish CA, Akbar AN, Paust S: Human natural killer cells mediate adaptive immunity to viral antigens. Sci Immunol 2019;4:pii:eaat8116.

16Przemska-Kosicka A, Childs CE, Maidens C, Dong H, Todd S, Gosney MA, Tuohy KM, Yaqoob P: Age-related changes in the natural killer cell response to seasonal influenza vaccination are not influenced by a synbiotic: a randomised controlled trial. Front Immunol 2018;9:591.

17Hazeldine J, Lord JM: The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res Rev 2013;12:1069–1078.

18Phan MT, Chun S, Kim SH, Ali AK, Lee SH, Kim S, Kim SH, Cho D: Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity. Hum Immunol 2017;78:103–112.

19Le Garff-Tavernier M, Béziat V, Decocq J, Siguret V, Gandjbakhch F, Pautas E, Debré P, Merle-Beral H, Vieillard V: Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 2010;9:527–535.

20Jiao Y, Huntington ND, Belz GT, Seillet C: Type 1 innate lymphoid cell biology: lessons learnt from natural killer cells. Front Immunol 2016;7:426.

21Mandal A, Viswanathan C: Natural killer cells: in health and disease. Hematol Oncol Stem Cell Ther 2015;8:47–55.

22Waggoner SN, Reighard SD, Gyurova IE, Cranert SA, Mahl SE, Karmele EP, McNally JP, Moran MT, Brooks TR, Yaqoob F, Rydyznski CE: Roles of natural killer cells in antiviral immunity. Curr Opin Virol 2016;16:15–23.

23Small CL, McCormick S, Gill N, Kugathasan K, Santosuosso M, Donaldson N, Heinrichs DE, Ashkar A, Xing Z: NK cells play a critical protective role in host defense against acute extracellular Staphylococcus aureus bacterial infection in the lung. J Immunol 2008;180:5558–5568.

      24Sagiv A, Burton DG, Moshayev Z, Vadai E, Wensveen F, Ben-Dor S, Golani O, Polic B, Krizhanovsky V: NKG2D ligands mediate immunosurveillance of senescent cells. Aging (Albany NY) 2016;8:328–344.

25Pereira BI, Devine OP, Vukmanovic-Stejic M, Chambers ES, Subramanian P, Patel N, Virasami A, Sebire NJ, Kinsler V, Valdovinos A, LeSaux CJ, Passos JF, Antoniou A, Rustin MHA, Campisi J, Akbar AN: Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition. Nat Commun 2019;10:2387.

      26Waggoner SN, Cornberg M, Selin LK, Welsh RM: Natural killer cells act as rheostats modulating antiviral T cells. Nature 2011;481:394–398.

27Martín-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, Sallusto F: Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004;5:1260–1265.

28Vitale M, Cantoni C, Della Chiesa M, Ferlazzo G, Carlomagno S, Pende D, Falco M, Pessino A, Muccio L, De Maria A, Marcenaro